Annual Report and AGM Notice for FY2025-26 submitted
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts more than Nifty Microcap 250 and 4.4 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Emmessar Biotech & Nutrition has submitted its 34th Annual Report and AGM Notice for FY 2025-26 under SEBI Regulation 34(1). The 34th AGM is scheduled for September 29, 2026 via video conferencing. Agenda includes adopting FY26 audited financials, re-appointing director Mr. Jeyavel Nadar by rotation, and 5-year re-appointments of MD Mr. Srinivasa Raghavan and Whole-time Director Mr. Jeyavel Nadar. MD pay scale Rs 2.2L to 4L per month, WTD pay scale Rs 1.2L to 2.5L per month.
Routine annual filing. Shareholders will vote on FY26 accounts and director re-appointments at the September 29, 2026 AGM. No major operational impact.